TransMedics Group Inc

Healthcare · Medical Devices

86.40$ -0.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

TransMedics Group Inc (TMDX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 190 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TMDX
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	66	81	97	114	109	122	144	157	144	161	174	190	668
Cost of Revenue	26	33	37	45	48	50	55	61	59	67	73	77	276
Gross Profit	41	48	60	69	61	72	88	97	85	93	101	113	392
Research & Development	38	11	11	14	14	16	17	16	15	21	25	32	92
Selling, General & Administrative	31	35	36	43	43	47	44	44	45	50	56	54	204
Total Operating Expenses	69	45	47	57	57	63	61	60	61	72	88	89	311
Operating Income	-28	2.6	12	13	3.9	8.6	27	37	23	21	13	24	82
Interest Expense	3.6	3.6	3.6	3.6	3.6	3.6	3.5	3.5	3.5	3.4	7.2	7.2	21
Pre-Tax Income	-27	3.9	12	12	4.2	7.0	27	36	23	22	8.5	19	73
Income Tax Expense	-1.5	-0.2	0.2	0.0	0.0	0.1	1.0	1.3	-1.3	-84	1.2	4.7	-79
Net Income	-25	4.0	12	12	4.2	6.9	26	35	24	105	7.3	15	152
EBITDA	-21	11	20	20	13	16	36	46	33	32	28	27	120

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings